CN Patent
CN105348138A — 四环素化合物的盐和多晶型物
Assigned to Paratek Pharmaceuticals Inc · Expires 2016-02-24 · 10y expired
What this patent protects
本文提供用于治疗四环素化合物敏感状态的化合物的晶形,包括盐和多晶型物在此被提供。晶体化合物用于治疗或预防疾病和病症例如细菌感染和肿瘤以及其它对于四环素类化合物通常已知的用途。
USPTO Abstract
本文提供用于治疗四环素化合物敏感状态的化合物的晶形,包括盐和多晶型物在此被提供。晶体化合物用于治疗或预防疾病和病症例如细菌感染和肿瘤以及其它对于四环素类化合物通常已知的用途。
Drugs covered by this patent
- Nuzyra (OMADACYCLINE TOSYLATE) · Paratek Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.